Pharmadrug Inc. announced the appointment of Nikolai Vassev to its board of directors, subject to regulatory approval. Mr. Vassev has strong pedigree in public markets and is a psychedelics industry pioneer. The Company believes Mr. Vassev will be instrumental is finding opportunities in whole plant-based products for Europe. Unfortunately, Alain Dobkin was required to resign from Pharmadrug's board due to a conflict of interest after accepting a senior position at an international investment bank in Israel.